Tirzepatide use is linked to lower risks of incident and progressive diabetic retinopathy compared with lifestyle intervention alone.

This research initiative highlights the importance of ethical and explainable artificial intelligence in workforce ...

The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell ...

In research published in the journal Gut, investigators from the University of Alabama at Birmingham report that restoring tryptophan metabolism in the gut microbiome can prevent or reverse diabetic ...

A higher incidence of new diabetic retinopathy has previously been reported in patients using GLP-1 receptor agonists. A new retrospective study suggested that use of tirzepatide was tied to a reduced ...

Diabetic retinopathy (DR), a leading cause of vision impairment among working-age adults, affects approximately 146 million individuals globally, with projections estimating an increase to 180 million ...

Sticking to your medication plan, managing your blood sugar, and taking care of your mental health can all be important components of self-care for diabetic retinopathy. Self‑care can’t cure diabetic ...

While eye care and regular eye exams are important for everyone, they're particularly vital for people with diabetes. Diabetes is a prevalent condition worldwide, affecting approximately 10% of the ...

As technology advances in diabetes care with continuous glucose monitors, insulin pumps and AI-driven alerts, another kind of intelligence is proving just as powerful: a dog’s nose. Across the country ...

Background/Aims Diabetic retinopathy (DR) is a major ocular complication of diabetes mellitus. While artificial intelligence (AI)-based DR screening tools have gained widespread adoption, most ...

Sun Pharma has launched an eye-opening awareness push about a common—and commonly overlooked—complication of diabetes. The “#SeeBeyondSugar” campaign, which began rolling out amid Nov. 14’s World ...